BR112022012111A2 - Sistema terapêutico transdérmico contendo agomelatina - Google Patents

Sistema terapêutico transdérmico contendo agomelatina

Info

Publication number
BR112022012111A2
BR112022012111A2 BR112022012111A BR112022012111A BR112022012111A2 BR 112022012111 A2 BR112022012111 A2 BR 112022012111A2 BR 112022012111 A BR112022012111 A BR 112022012111A BR 112022012111 A BR112022012111 A BR 112022012111A BR 112022012111 A2 BR112022012111 A2 BR 112022012111A2
Authority
BR
Brazil
Prior art keywords
transdermal therapeutic
agomelatin
agomelatine
tts
system containing
Prior art date
Application number
BR112022012111A
Other languages
English (en)
Inventor
Mohr Patrick
Rietscher René
Eifler René
Bourquain Olga
Original Assignee
Lts Lohmann Therapie Systeme Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lts Lohmann Therapie Systeme Ag filed Critical Lts Lohmann Therapie Systeme Ag
Publication of BR112022012111A2 publication Critical patent/BR112022012111A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Inorganic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

SISTEMA TERAPÊUTICO TRANSDÉRMICO CONTENDO AGOMELATINA. A presente invenção refere-se a sistemas terapêuticos transdérmicos (TTS) para a administração transdérmica de agomelatina compreendendo uma estrutura de camada autoadesiva contendo uma quantidade terapeuticamente eficaz de agomelatina, tal TTS de agomelatina para uso em um método de tratamento, um método de tratamento compreendendo a aplicação de tal TTS de agomelatina e a processos de fabricação de tal TTS.
BR112022012111A 2019-12-20 2020-10-02 Sistema terapêutico transdérmico contendo agomelatina BR112022012111A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP19218599 2019-12-20
PCT/EP2020/077737 WO2020260727A1 (en) 2019-12-20 2020-10-02 Transdermal therapeutic system containing agomelatine

Publications (1)

Publication Number Publication Date
BR112022012111A2 true BR112022012111A2 (pt) 2022-08-30

Family

ID=69411126

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112022012111A BR112022012111A2 (pt) 2019-12-20 2020-10-02 Sistema terapêutico transdérmico contendo agomelatina

Country Status (8)

Country Link
US (1) US20240285546A1 (pt)
EP (1) EP4076382B1 (pt)
JP (1) JP7688036B2 (pt)
CN (1) CN113613637B (pt)
BR (1) BR112022012111A2 (pt)
CA (1) CA3162229A1 (pt)
ES (1) ES2980467T3 (pt)
WO (1) WO2020260727A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102020107937A1 (de) * 2020-03-23 2021-09-23 Lts Lohmann Therapie-Systeme Ag DMEH - Enhancer
CN114042055A (zh) * 2021-12-29 2022-02-15 江苏山信药业有限公司 一种阿戈美拉汀透皮贴剂及其制备方法和其应用
WO2024145846A1 (zh) * 2023-01-04 2024-07-11 新领医药技术(深圳)有限公司 稳定的透皮给药试剂盒及其制备方法和用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5656286A (en) * 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
JP5704801B2 (ja) 2008-08-21 2015-04-22 ニプロパッチ株式会社 粘着性組成物及び経皮吸収型製剤
RU2544702C2 (ru) 2009-04-24 2015-03-20 Хенкель Корпорейшн Клеи на основе силикон-акрилового гибридного полимера
LT3257504T (lt) * 2009-12-22 2024-08-26 UCB Biopharma SRL Polivinilpirolidonas, skirtas nekristalinės formos kietos rotigotino dispersijos stabilizavimui
WO2014024896A1 (ja) * 2012-08-08 2014-02-13 株式会社メドレックス アゴメラチンを含有する貼付剤組成物
TW201431570A (zh) * 2012-11-22 2014-08-16 Ucb Pharma Gmbh 用於經皮投服羅替戈汀（Ｒｏｔｉｇｏｔｉｎｅ）之多天式貼片
AP2015008920A0 (en) * 2013-06-04 2015-12-31 Lohmann Therapie Syst Lts Transdermal delivery system
CN106456566B (zh) * 2014-05-20 2020-06-16 Lts勒曼治疗系统股份公司 含罗替戈汀的经皮递送系统
WO2016109483A1 (en) 2014-12-30 2016-07-07 Noven Pharmaceuticals, Inc. Transdermal drug delivery systems for agomelatine
CN115813888A (zh) * 2016-12-20 2023-03-21 罗曼治疗系统股份公司 包含阿塞那平的透皮治疗系统
CN110151735B (zh) * 2019-06-06 2021-07-06 深圳市泛谷药业股份有限公司 一种阿戈美拉汀透皮贴剂及其制备方法

Also Published As

Publication number Publication date
US20240285546A1 (en) 2024-08-29
ES2980467T3 (es) 2024-10-01
JP7688036B2 (ja) 2025-06-03
CA3162229A1 (en) 2020-12-30
CN113613637A (zh) 2021-11-05
EP4076382B1 (en) 2024-03-20
EP4076382C0 (en) 2024-03-20
JP2023506538A (ja) 2023-02-16
WO2020260727A1 (en) 2020-12-30
CN113613637B (zh) 2024-08-06
EP4076382A1 (en) 2022-10-26

Similar Documents

Publication Publication Date Title
MX382195B (es) Sistema terapeutico transdermico que contiene asenapina
BR112022009849A2 (pt) Sistema terapêutico transmucosa contendo agomelatina
BR112022012111A2 (pt) Sistema terapêutico transdérmico contendo agomelatina
BR112016011166A8 (pt) Formulação farmacêutica, uso de ll-37 ou um sal farmaceuticamente aceitável do mesmo, e, método para tratar topicamente uma úlcera crônica
CO2020013600A2 (es) Tratamiento de la hidradenitis supurativa mediante el uso de inhibidores de jak
MX347195B (es) Sistema de administración transdérmica de fármacos y método para usar el mismo.
BR122013013162A2 (pt) Uso de rivastigmina para preparar um sistema terapêutico transdérmico (tts)
MX2020014286A (es) Sistema terapeutico transdermico que contiene asenapina.
PH12015502550A1 (en) Transdermal delivery system
MX2016008138A (es) Sistema para el suministro transdermico de ingredientes activos.
BRPI0713257B8 (pt) sistema terapêutico transdérmico para a aplicação de norelgestromina
MX382132B (es) Sistema terapeutico transdermico que contiene asenapina y polisiloxano o poliisobutileno
BR112013024585A8 (pt) formas de dosagem farmacêutica de liberação controlada
BR112016012615A8 (pt) sistemas, e kit
MY183873A (en) Transdermal therapeutic system for application of an agent
EA201500553A1 (ru) Многодневный пластырь для чрескожного введения ротиготина
MX2012002727A (es) Sistema terapeutico transdermico para administrar fentanilo o un analogo del mismo.
EA201591124A1 (ru) Трансдермальная система доставки
BR112019024566A2 (pt) inibidores de pirazol magl
BR112022012139A2 (pt) Sistema terapêutico transmucosal contendo agomelatina
EA201400628A1 (ru) Трансдермальная терапевтическая система для введения фентанила или его аналога
WO2016149077A3 (en) Fentanyl transdermal delivery system
BR112019007325A2 (pt) sistema terapêutico tópico de duas camadas
MX2015010967A (es) Formulaciones transdermicas de laquinimod.
BR112021024461A2 (pt) Sistema terapêutico transdérmico compreendendo uma camada contendo agente ativo compreendendo um polímero contendo silicone e uma camada de contato com a pele compreendendo um adesivo de gel de silicone

Legal Events

Date Code Title Description
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]